|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Total operating expenses | |||||
| Other income / (expense) | |||||
| Interest income | |||||
| Other expense: | |||||
| Change in fair value of convertible notes payable | |||||
| Other expense | |||||
| Total other expense, net | |||||
| Net loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Net loss | |||||
| Currency translation adjustment | |||||
| Unrealized gain on investments | |||||
| Comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic | |||||
| Series A Non-voting Convertible Preferred Stock | |||||
| Total net loss per share attributable to common stockholders, basic | |||||
| Net loss per share attributable to common stockholders, diluted | |||||
| Series A Non-voting Convertible Preferred Stock | |||||
| Total net loss per share attributable to common stockholders, diluted | |||||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | |||||
| Series A Non-voting Convertible Preferred Stock | |||||
| Total weighted-average shares used in computing net loss per share attributable to common stockholders, basic | |||||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | |||||
| Series A Non-voting Convertible Preferred Stock | |||||
| Total weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | |||||
Loading...